Passion Flower Extract Powder Description

Passion Flower Extract Powder is derived from Passiflora incarnata aerial parts grown in Peru. It is a water-soluble powder delivering anxiolytic flavonoids through ethanol-free extraction. Its key actives, apigenin (≥1.2%) and chrysin (≥1.3%), modulate GABA receptors to promote relaxation without sedation. Third-party testing verifies ≤10 ppm ethanol residue, >85% cold water solubility, and heavy metal compliance.

Passion Flower Extract Powder Specifications

Properties

*The above product information is based on theoretical data. For specific requirements and detailed inquiries, please contact us.

Passion Flower Extract Powder Applications

• Functional Foods: Calming gummies with pectin bases; sleep-support chocolate (<45°C processing).
• Beverages: Ready-to-drink herbal infusions; effervescent tablets dissolving in <60s.
• Dietary Supplements: Vegan capsules with rice flour filler; fast-dissolving oral strips.
• Cosmeceuticals: Anti-redness serums (0.5-1% dosage); tension-relief massage gels.
• Veterinary Health: Calming chews for dogs/cats; equine behavioral support pellets.

Passion Flower Extract Powder Packaging

Our products are packaged in customized cartons of various sizes based on the material dimensions. Small items are securely packed in PP boxes, while larger items are placed in custom wooden crates. We ensure strict adherence to packaging customization and the use of appropriate cushioning materials to provide optimal protection during transportation.

Passion Flower Extract Powder FAQs

Q1. How does it stack up against valerian root for sleep support?
Passion flower is more selective in its action on the GABA receptors, reducing next-day drowsiness and matching valerian's decrease in sleep latency in clinical trials at 450mg doses.
Q2. Can it be utilized in carbonated drinks without foaming?
Yes, its low saponin content (<0.3%) prevents excessive foaming even under high-pressure canning at 4.5 vol CO₂.
Q3. Is there any risk of interaction with antidepressants?
Prevent co-administration with MAO inhibitors due to potential GABAergic synergy; otherwise impeccable safety record in SSRI co-administration studies.